Human Immunology News 4.39 October 4, 2016 | |
| |
TOP STORY‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors Scientists have engineered human immune cells that can precisely locate diseased cells anywhere in the body and execute a wide range of customizable responses, including the delivery of drugs or other therapeutic payloads directly to tumors or other unhealthy tissues. [Press release from UC San Francisco discussing online prepublication in Cell] Press Release | Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)A Three-Stage Intrathymic Development Pathway for the Mucosal-Associated Invariant T Cell Lineage Researchers defined three developmental stages and checkpoints for the mucosal-associated invariant T cell (MAIT) cell lineage in humans and mice. Stage 1 and stage 2 MAIT cells predominated in thymus, while stage 3 cells progressively increased in abundance extrathymically. [Nat Immunol] Abstract Investigators report on the preclinical activity, safety and pharmacokinetic properties of MGD011. The activity of MGD011 was evaluated in several in vitro and in vivo models. [Clin Cancer Res] Abstract CD16 Is Indispensable for Antibody-Dependent Cellular Cytotoxicity by Human Monocytes The authors found that human CD16-expressing monocytes have a broad spectrum of antibody-dependent cellular cytotoxicity capacities and can kill cancer cell lines, primary leukemic cells and hepatitis B virus-infected cells in the presence of specific antibodies. [Sci Rep] Full Article Researchers studied the effects of statins on human dendritic cells (DCs) maturation and T-cell activation. Human peripheral blood monocytes were differentiated to DCs and stimulated with oxLDL. [J Am Heart Assoc] Full Article Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells Given that O-linked N-acetylglucosamine (O-GlcNAc) appears to regulate cell signaling pathways and protein activity similarly to phosphorylation, the authors performed a comprehensive analysis of O-GlcNAc during T cell activation to address the functional importance of this modification and to identify the modified proteins. [J Immunol] Abstract | Full Article Maintenance of the EBV-Specific CD8+ TCRαβ Repertoire in Immunosuppressed Lung Transplant Recipients Scientists used a novel single-cell T-cell receptor (TCR)αβ multiplex-nested reverse transcriptase PCR to dissect TCRαβ clonal diversity within GLCTLVAML-specific CD8+ T cells in healthy individuals and immunocompromised lung transplant recipients. [Immunol Cell Biol] Full Article CD8+ T-Cell Specificity Is Compromised at a Defined MHCI/CD8 Affinity Threshold Scientists used a panel of major histocompatibility complex class I (MHCI) mutants with altered CD8 binding properties to show that T-cell receptor-mediated antigen specificity is delimited by a peptide-MHCI/CD8 affinity threshold. [Immunol Cell Biol] Abstract | Full Article Significant negative correlations were observed between indices of microvascular structure and circulating T-regulatory lymphocytes. A direct correlation was observed between media to lumen ratio of subcutaneous small arteries and circulating Th17 lymphocytes. [Am J Hypertens] Abstract Scientists proposed a backbone of six antibodies and an efficient gating strategy to identify, in a single analysis tube, a large number of B-cell subsets covering the whole B-cell differentiation from precursors to memory and plasma cells. [PLoS One] Full Article Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSShaping Variation in the Human Immune System Immune responses demonstrate a high level of intra-species variation, compensating for the specialization capacity of pathogens. The recent advent of in-depth immune phenotyping projects in large-scale cohorts has allowed a first look into the factors that shape the inter-individual diversity of the human immune system. [Trends Immunol] Abstract Adoptive cell transfer (ACT) is a therapeutic modality that has intrigued physicians and researchers for its many theoretical benefits. Preclinical investigations and human trials have utilized natural killer cells, dendritic cells, macrophages, T-cells or B-cells for ACT with the most intense research focused on T-cell ACT. [Cancers] Full Article Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
INDUSTRY NEWS$10 Million Gift Creates Bursky Center for Human Immunology and Immunotherapy Washington University School of Medicine in St. Louis has received a $10 million gift to support research that harnesses the immune system to fight cancer, infectious diseases, and disorders caused by autoimmunity and immune deficiencies. [Washington University in St. Louis] Press Release Dr. Allen Eaves of STEMCELL Technologies Inc. Named EY Entrepreneur Of The Year™ Pacific 2016 Dr. Allen Eaves, Chairman, President and Chief Executive Officer of STEMCELL Technologies, a global biotechnology company that supplies tools and services to enable life science research, is this year’s Entrepreneur Of The Year Pacific winner. [Ernst & Young (CNW Group Ltd.)] Press Release Aurinia Pharmaceuticals Inc. announced that in addition to voclosporin achieving its primary endpoint of complete remission at 24 weeks, both doses of voclosporin when added to the current standard of care of Mycophenolate Mofetil and a forced oral corticosteroid taper have met all 24-week pre-specified secondary endpoints vs the control group. [Aurinia Pharmaceuticals Inc.] Press Release Medicine Nobel for Research on How Cells ‘Eat Themselves’ Molecular biologist Yoshinori Ohsumi has won the 2016 Nobel Prize in Physiology or Medicine for his work in the field of autophagy: the processes by which the cell digests and recycles its own components. [Nature News] Editorial | Press Release | |
| |
POLICY NEWSDemocratic Databases: Science on GitHub Scientists are turning to a software-development site to share data and code. [Nature Toolbox] Editorial Biologists Plan Scoring System for Antibodies Biomedical experts plan to create a scoring system that will help researchers choose reliable antibodies for their experiments. The only problems: figuring out how such a ranking would work — and getting manufacturers to adopt the standard. [Nature News] Editorial UK Bioethicists Eye Designer Babies and CRISPR Cows From designer babies to engineered mosquitoes, advances in genome-editing technologies such as CRISPR–Cas9 have raised the possibility of tremendous scientific advances — and serious ethical concerns. [Nature News] Editorial
| |
EVENTSNEW Advances in Cell Engineering, Imaging and Screening NEW British Society for Immunology Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Position – Immunology (Klinikum der Universität München) NEW Faculty Positions – Immunology (Ohio State University) Research Associate – Cellular Therapy (California Institute for Biomedical Research) Postdoctoral Fellow – Molecular Immunology (University of California San Diego School of Medicine) Faculty Positions – Various Areas (Jackson Laboratory) Faculty Position – Immunology (Vanderbilt University Medical Center) Postdoctoral Fellow – Mucosal Immunology (University of Utah) Postdoctoral Fellow – Metastatic Breast Cancer (Purdue Center for Cancer Research) Assistant Associate – Cancer Immunology (Fred Hutchinson Cancer Research Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|